Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hope V"'
Autor:
Emanuel E; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom., Slater L; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom. Electronic address: lucinda.slater@ukhsa.gov.uk., Croxford S; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom; St Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, United Kingdom., Edmundson C; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom., Ibitoye A; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom., Njoroge J; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom., Ijaz S; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom., Hope V; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom; Liverpool John Moores University, Liverpool, United Kingdom., Platt L; London School of Hygiene and Tropical Medicine, London, United Kingdom., Phipps E; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom., Desai M; Blood Safety, Hepatitis, STI and HIV Service, UK Health Security Agency, London, United Kingdom.
Publikováno v:
Public health [Public Health] 2023 Dec; Vol. 225, pp. 79-86. Date of Electronic Publication: 2023 Nov 01.
Autor:
Uusküla A; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia., Rannap J; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia., Weijler L; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal., Abagiu A; National Institute for Infectious diseases 'Professor Dr Matei Bals', Bucharest, Romania., Arendt V; Service National des Maladies Infectieuses, Centre Hospitalier de Luxembourg, Luxembourg., Barrio G; National School of Public Health, Carlos III Health Institute, Madrid, Spain., Barros H; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal., Brummer-Korvenkontio H; Finnish Institute for Health and Welfare, Helsinki, Finland., Casabona J; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain.; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Croes E; Trimbos Institute, Utrecht, the Netherlands., Jarlais DD; School of Global Public Health, New York University, New York, NY, 10012, USA., Seguin-Devaux C; Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg., Dudás M; National Public Health Center, Budapest, Hungary., Eritsyan K; National Research University Higher School of Economics, St Petersburg, Russia., Folch C; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain.; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Hatzakis A; Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Heimer R; Department of the Epidemiology of Microbial Diseases, Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA., Heinsbroek E; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK., Hope V; Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London, UK.; Public Health Institute, Liverpool John Moores University, Liverpool, UK., Jipa R; National Institute for Infectious diseases 'Professor Dr Matei Bals', Bucharest, Romania., Ķīvīte-Urtāne A; Institute of Public Health, Riga Stradins University, Riga, Latvia., Levina O; National Research University Higher School of Economics, St Petersburg, Russia.; Acuity Systems, Herndon, VA, USA., Lyubimova A; National Research University Higher School of Economics, St Petersburg, Russia., Malczewski A; EMCDDA Polish National Focal Point, National Bureau for Drug Prevention, Warsaw, Poland., Matser A; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam Infection andd Immunity Institute, Amsterdam, the Netherlands., McAuley A; Public Health Scotland, Meridian Court, Glasgow, Scotland, UK.; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK., Meireles P; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal., Mravčík V; Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.; Společnost Podané ruce, Brno, Czech Republic.; Klinika Podané ruce, Brno, Czech Republic., Op de Coul E; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Ojavee SE; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland., Parés-Badell O; Agència de Salut Pública de Barcelona, Barcelona, Spain., Prins M; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Infectious Diseases, Amsterdam Infection andd Immunity Institute, Amsterdam, the Netherlands., Pulido J; National School of Public Health, Carlos III Health Institute, Madrid, Spain.; Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.; Department of Public Health and Maternal and Child Health, Complutense University of Madrid, Madrid, Spain., Romanyak E; Non-Profit Partnership ESVERO, 12, Moscow, Russia., Rosinska M; Department of Infectious Diseases Epidemiology and Surveillance, National Institute of Public Health NIH, National Research Institute, Warsaw, Poland., Seyler T; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal., Stone J; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Sypsa V; Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Talu A; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia., Tarján A; Hungarian Reitox National Focal Point, Budapest, Hungary., Taylor A; Emeritus Professor of Public Health, School of Education and Social Sciences, University of West Scotland, Paisley, Scotland, UK., Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Vorobjov S; Department of Drug and Infectious Diseases Epidemiology, National Institute for Health Development, Tallinn, Estonia., Dolan K; National Drug and Alcohol Research Centre, the University of New South Wales, Sydney, NSW, Australia., Wiessing L; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
Publikováno v:
Addiction (Abingdon, England) [Addiction] 2023 Nov; Vol. 118 (11), pp. 2177-2192. Date of Electronic Publication: 2023 Aug 03.
Autor:
Croxford S; UK Health Security Agency, London, UK., Emanuel E; UK Health Security Agency, London, UK., Shah A; UK Health Security Agency, London, UK., Chau C; UK Health Security Agency, London, UK., Hope V; UK Health Security Agency, London, UK.; Liverpool John Moores University, Liverpool, UK., Desai M; UK Health Security Agency, London, UK., Ijaz S; UK Health Security Agency, London, UK., Shute J; UK Health Security Agency, London, UK., Edmundson C; UK Health Security Agency, London, UK., Harris RJ; UK Health Security Agency, London, UK., Delpech V; UK Health Security Agency, London, UK., Phipps E; UK Health Security Agency, London, UK.
Publikováno v:
HIV medicine [HIV Med] 2022 Oct; Vol. 23 (9), pp. 978-989. Date of Electronic Publication: 2022 Mar 30.
Autor:
Doran J; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.; National Infection Service, Public Health England, London, UK., Hope V; Public Health Institute, Liverpool John Moores University, Liverpool, UK., Wright T; Division of Psychiatry, University College London, London, UK., Scott J; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK., Ciccarone D; Department of Family and Community Medicine, University of California, San Francisco, USA., Harris M; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Publikováno v:
Drug and alcohol review [Drug Alcohol Rev] 2022 Mar; Vol. 41 (3), pp. 677-685. Date of Electronic Publication: 2021 Oct 03.
Autor:
Wiessing L; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal., Kalamara E; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal.; EASO MTC Block A, Winemakers Wharf, Grand Harbour Valletta, Malta., Stone J; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Altan P; Ministry of Health, Public Health General Directorate, Ankara, Turkey., Van Baelen L; Sciensano, Epidemiology and public health, Lifestyle and chronic diseases, Brussels, Belgium., Fotiou A; University Mental Health, Neurosciences, & Precision Medicine Research Institute, Athens, Greece., Garcia D; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal.; NOVA FCSH - Universidade Nova de Lisboa, Lisbon, Portugal., Goulao J; General Director on Addictive Behaviours and Dependencies, Ministry of Health, Lisbon, Portugal., Guarita B; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal., Hope V; Public Health Institute, Liverpool John Moores University, Liverpool, United Kingdom., Jauffret-Roustide M; Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR8044/EHESS), Paris, France.; Santé Publique France, Saint-Maurice, France.; Baldy Center for Law and Social Policy, Buffalo University of Social Sciences, New York, United States.; British Columbia Centre on Substance Use (BCCSU), Vancouver, Canada., Jurgelaitienė L; Drug, Tobacco and Alcohol Control Department, Vilnius, Lithuania.; Social Innovations and Science Centre, Vilnius, Lithuania., Kåberg M; Stockholm Needle Exchange, Stockholm Centre for Dependency Disorders, Stockholm, Sweden.; Department of Medicine Huddinge, Division of Infection and Dermatology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden., Kamarulzaman A; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lemsalu L; Centre for Prevention of Drug Addiction and Infectious Diseases, National Institute for Health Development, Tallinn, Estonia., Kivite-Urtane A; Riga Stradins University, Institute of Public Health, Riga, Latvia., Kolarić B; Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia.; Medical Faculty, University of Rijeka, Rijeka, Croatia., Montanari L; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal., Rosińska M; National Institute of Public Health NIH - National Research Institute, Warsaw, Poland., Sava L; National Antidrug Agency - Ministry of Internal Affairs, Bucharest, Romania., Horváth I; Gesundheit Österreich GmbH - Austrian National Public Health Institution, International Affairs and Consulting, Vienna, Austria., Seyler T; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal., Sypsa V; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Tarján A; Hungarian Reitox National Focal Point, Budapest, Hungary., Yiasemi I; Monitoring Department, Cyprus National Addictions Authority, Nicosia, Cyprus., Zimmermann R; Robert Koch Institute, Department of Infectious Disease Epidemiology, Berlin, Germany., Ferri M; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Public Health Unit, Lisbon, Portugal., Dolan K; Program of International Research and Training, National Drug and Alcohol Research Centre, Sydney, Australia., Uusküla A; Department of Family Medicine and Public Health, University of Tartu, Tartu, Estonia., Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2021 Dec; Vol. 26 (49).
Autor:
Dunleavy K; School of Media, Culture and Society, University of the West of Scotland, Paisley, PA1 2BE, Scotland, United Kingdom. Electronic address: karen.dunleavy@uws.ac.uk., Hope V; Public Health Institute, Liverpool John Moores University, Liverpool, England, United Kingdom., Roy K; Health Protection Scotland, NHS National Services Scotland, Glasgow, Scotland, United Kingdom., Taylor A; School of Media, Culture and Society, University of the West of Scotland, Paisley, PA1 2BE, Scotland, United Kingdom.
Publikováno v:
The International journal on drug policy [Int J Drug Policy] 2019 Mar; Vol. 65, pp. 65-72. Date of Electronic Publication: 2019 Jan 18.
Autor:
McGowan CR; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom; Humanitarian Public Health Technical Unit, Save the Children UK, London, United Kingdom. Electronic address: Catherine.McGowan@lshtm.ac.uk., Harris M; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom., Platt L; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom., Hope V; Public Health Institute, Liverpool John Moores University, Liverpool, United Kingdom., Rhodes T; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom; Centre for Social Research in Health, University of New South Wales, Australia.
Publikováno v:
The International journal on drug policy [Int J Drug Policy] 2018 Aug; Vol. 58, pp. 31-36. Date of Electronic Publication: 2018 May 12.
Autor:
Zahnow R; School of Social Science, The University of Queensland, St Lucia, Brisbane, Queensland, 4072, Australia. Electronic address: r.zahnow@uq.edu.au., McVeigh J; Public Health Institute, Liverpool John Moore's University, Henry Cotton Campus, 15-21 Webster Street, Liverpool, L3 2ET, United Kingdom. Electronic address: J.McVeigh@ljmu.ac.uk., Bates G; Public Health Institute, Liverpool John Moore's University, Henry Cotton Campus, 15-21 Webster Street, Liverpool, L3 2ET, United Kingdom. Electronic address: G.P.Bates@2016.ljmu.ac.uk., Hope V; Public Health Institute, Liverpool John Moore's University, Henry Cotton Campus, 15-21 Webster Street, Liverpool, L3 2ET, United Kingdom. Electronic address: V.D.Hope@ljmu.ac.uk., Kean J; Public Health Institute, Liverpool John Moore's University, Henry Cotton Campus, 15-21 Webster Street, Liverpool, L3 2ET, United Kingdom. Electronic address: joseph@ninezerofive.org., Campbell J; Research, Development and Innovation at Scottish National Blood Transfusion Service, Edinburgh, United Kingdom. Electronic address: John.Campbell@ggc.scot.nhs.uk., Smith J; Public Health Wales, Health Promotion, Cardiff, United Kingdom. Electronic address: Josie.Smith@wales.nhs.uk.
Publikováno v:
The International journal on drug policy [Int J Drug Policy] 2018 May; Vol. 55, pp. 105-112. Date of Electronic Publication: 2018 Mar 20.
Autor:
Dunleavy K; School of Media, Culture and Society, University of the West of Scotland, Paisley, PA1 2BE, Scotland, United Kingdom. Electronic address: karen.dunleavy@uws.ac.uk., Munro A; School of Media, Culture and Society, University of the West of Scotland, Paisley, PA1 2BE, Scotland, United Kingdom., Roy K; Health Protection Scotland, NHS National Services Scotland, Glasgow, Scotland, United Kingdom., Hutchinson S; Health Protection Scotland, NHS National Services Scotland, Glasgow, Scotland, United Kingdom; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, United Kingdom., Palmateer N; Health Protection Scotland, NHS National Services Scotland, Glasgow, Scotland, United Kingdom; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, United Kingdom., Knox T; School of Media, Culture and Society, University of the West of Scotland, Paisley, PA1 2BE, Scotland, United Kingdom., Goldberg D; Health Protection Scotland, NHS National Services Scotland, Glasgow, Scotland, United Kingdom., Hope V; Public Health Institute, Liverpool John Moores University, Liverpool, England, United Kingdom., Campbell J; NHS Greater Glasgow and Clyde, Festival Business Park, Brand St, Glasgow, Scotland, United Kingdom., Hamilton E; Scottish Drugs Forum, 91 Mitchell Street, Glasgow, Scotland, United Kingdom., Liddell D; Scottish Drugs Forum, 91 Mitchell Street, Glasgow, Scotland, United Kingdom., Penrice G; Gartnavel Royal Hospital, West House, Glasgow, Scotland, United Kingdom., Taylor A; School of Media, Culture and Society, University of the West of Scotland, Paisley, PA1 2BE, Scotland, United Kingdom.
Publikováno v:
The International journal on drug policy [Int J Drug Policy] 2018 Mar; Vol. 53, pp. 45-54. Date of Electronic Publication: 2017 Dec 24.
Autor:
Hope VD; Centre for Infectious Disease Surveillance and Control, Public Health England, London, United Kingdom., Harris RJ, De Angelis D, Croxford S, Marongiu A, Parry JV, Ncube F
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2014 Apr 10; Vol. 19 (14). Date of Electronic Publication: 2014 Apr 10.